Clinical Study
Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson’s Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
Table 2
Parkinson’s Disease Sleep Scale (PDSS) subscale scores at baseline and 3 months in patients with Parkinson’s disease receiving rotigotine.
|